ENOV
Price
$30.66
Change
-$0.18 (-0.58%)
Updated
Sep 3 closing price
Capitalization
1.75B
56 days until earnings call
LAB
Price
$1.29
Change
+$0.05 (+4.03%)
Updated
Sep 3 closing price
Capitalization
492.77M
68 days until earnings call
Interact to see
Advertisement

ENOV vs LAB

Header iconENOV vs LAB Comparison
Open Charts ENOV vs LABBanner chart's image
Enovis
Price$30.66
Change-$0.18 (-0.58%)
Volume$1.27M
Capitalization1.75B
Standard BioTools
Price$1.29
Change+$0.05 (+4.03%)
Volume$1.54M
Capitalization492.77M
ENOV vs LAB Comparison Chart in %
Loading...
ENOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENOV vs. LAB commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a StrongBuy and LAB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ENOV: $30.66 vs. LAB: $1.29)
Brand notoriety: ENOV and LAB are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ENOV: 96% vs. LAB: 110%
Market capitalization -- ENOV: $1.75B vs. LAB: $492.77M
ENOV [@Medical/Nursing Services] is valued at $1.75B. LAB’s [@Medical/Nursing Services] market capitalization is $492.77M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.05B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENOV’s FA Score shows that 0 FA rating(s) are green whileLAB’s FA Score has 0 green FA rating(s).

  • ENOV’s FA Score: 0 green, 5 red.
  • LAB’s FA Score: 0 green, 5 red.
According to our system of comparison, LAB is a better buy in the long-term than ENOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENOV’s TA Score shows that 7 TA indicator(s) are bullish while LAB’s TA Score has 4 bullish TA indicator(s).

  • ENOV’s TA Score: 7 bullish, 3 bearish.
  • LAB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ENOV is a better buy in the short-term than LAB.

Price Growth

ENOV (@Medical/Nursing Services) experienced а -1.16% price change this week, while LAB (@Medical/Nursing Services) price change was +0.78% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.08%. For the same industry, the average monthly price growth was +1.73%, and the average quarterly price growth was +23.90%.

Reported Earning Dates

ENOV is expected to report earnings on Oct 30, 2025.

LAB is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.08% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENOV($1.75B) has a higher market cap than LAB($493M). LAB YTD gains are higher at: -26.286 vs. ENOV (-30.128). LAB has higher annual earnings (EBITDA): -120.98M vs. ENOV (-472.1M). LAB has more cash in the bank: 237M vs. ENOV (44.1M). LAB has less debt than ENOV: LAB (28.6M) vs ENOV (1.47B). ENOV has higher revenues than LAB: ENOV (2.19B) vs LAB (172M).
ENOVLABENOV / LAB
Capitalization1.75B493M356%
EBITDA-472.1M-120.98M390%
Gain YTD-30.128-26.286115%
P/E RatioN/AN/A-
Revenue2.19B172M1,273%
Total Cash44.1M237M19%
Total Debt1.47B28.6M5,122%
FUNDAMENTALS RATINGS
ENOV vs LAB: Fundamental Ratings
ENOV
LAB
OUTLOOK RATING
1..100
6174
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
5760
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LAB's Valuation (34) in the Medical Specialties industry is somewhat better than the same rating for ENOV (79) in the Industrial Machinery industry. This means that LAB’s stock grew somewhat faster than ENOV’s over the last 12 months.

LAB's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that LAB’s stock grew similarly to ENOV’s over the last 12 months.

LAB's SMR Rating (96) in the Medical Specialties industry is in the same range as ENOV (97) in the Industrial Machinery industry. This means that LAB’s stock grew similarly to ENOV’s over the last 12 months.

ENOV's Price Growth Rating (57) in the Industrial Machinery industry is in the same range as LAB (60) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to LAB’s over the last 12 months.

ENOV's P/E Growth Rating (98) in the Industrial Machinery industry is in the same range as LAB (100) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to LAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENOVLAB
RSI
ODDS (%)
Bullish Trend 1 day ago
55%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 23 days ago
60%
Bullish Trend 18 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ENOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LCORX23.420.08
+0.34%
Leuthold Core Investment Retail
VEIGX37.83-0.03
-0.08%
Vanguard Global ESG Select Stk Investor
GSCOX28.90-0.03
-0.10%
Goldman Sachs Small Cap Gr Insghts C
JSMGX28.02-0.12
-0.43%
Janus Henderson Triton I
CMCMX8.89-0.12
-1.33%
Conestoga Discovery Investors

ENOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with CNMD. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then CNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENOV
1D Price
Change %
ENOV100%
-0.58%
CNMD - ENOV
59%
Loosely correlated
-1.27%
IART - ENOV
56%
Loosely correlated
-0.20%
ITGR - ENOV
54%
Loosely correlated
-1.06%
NPO - ENOV
51%
Loosely correlated
-1.47%
DOV - ENOV
50%
Loosely correlated
-0.59%
More

LAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, LAB has been loosely correlated with CLPT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LAB jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LAB
1D Price
Change %
LAB100%
+4.03%
CLPT - LAB
45%
Loosely correlated
-1.73%
TMCI - LAB
44%
Loosely correlated
+1.12%
CERS - LAB
44%
Loosely correlated
+3.15%
ENOV - LAB
44%
Loosely correlated
-0.58%
BLFS - LAB
42%
Loosely correlated
-1.18%
More